Doctor reacts to AI breast cancer tool
Summary
Clairity Breast is a new AI tool approved by the FDA that assesses a woman’s risk of breast cancer over five years. It costs $249 and uses artificial intelligence to analyze mammogram images. Dr. Céline Gounder shared her opinion on the tool in a CBS News segment.Key Facts
- Clairity Breast is an AI (artificial intelligence) tool designed for breast cancer risk assessment.
- The tool provides a five-year risk estimate for breast cancer.
- It has been approved by the FDA (Food and Drug Administration).
- The cost for using Clairity Breast is $249.
- The tool analyzes mammogram images to make its risk prediction.
- Dr. Céline Gounder gave her expert reaction to the tool in a CBS News report.
- This tool aims to help doctors and patients better understand breast cancer risk.
- It represents a new use of AI technology in medical imaging and cancer prevention.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
